A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol

NCT00645151 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

512

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: Atorvastatin
DRUG: Atorvastatin
DRUG: Atorvastatin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.